At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biocontainment Device With Aerosol Clearance for Aerosol Generating Procedures
In Brief
A clinical study evaluating Biocontainment Device For Aerosol Generating Procedures (Biobox) and Control for aerosol generating procedures for Protective Device (Physical Object) and 2 related conditions. Completed, enrolled 37 participants across 1 site.
Detailed Summary
The primary goal of this study is to assess use of a biocontainment device for planned airway procedures under general anesthesia. This will serve as a platform for using this device as a novel biocontainment and aerosol evacuation system as part of rapid sequence intubation protocols for COVID-19 patients. We hypothesize that airway procedures with the aerosol biocontainment device will be safe and effective with airway procedure times approaching times for airway procedures without the device.
Study Details
Timeline
Interventions
The intervention consists of a biocontainment and aerosol evacuation device (Biobox) that will be placed around a patient prior to the airway procedure and remain in place throughout the airway procedure. The Biobox device is manufactured by National Flag and consists of a re-useable frame with a disposable, plastic torso drape. This is a new device that has not been used previously in a healthcare setting.
There is no control device for the aerosol containment device. As such, intubation without a device will serve as the control/placebo arm for this trial.